Device Trial Radar · NCT03692598
Study of Transcatheter Tricuspid Annular Repair
Last checked: Nov 20, 2026Latest source record: Oct 23, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
60
Planned (sponsor's estimate)
Start
Dec 2016
Primary completion
Dec 2025
Study completion Dec 2026
Sponsor
- Lead sponsor
- Micro Interventional DevicesNot on our public-company list
- Sponsor type
- Industry
- First posted
- Oct 2, 2018
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of the study is to evaluate the safety and performance of the MIA Minimally Invasive Annuloplasty Device in patients with chronic functional tricuspid regurgitation.
Conditions
- Tricuspid Regurgitation
Interventions
MIA, Minimally Invasive Annuloplasty Device - SurgicalDevice
Eligible patients will receive implantation of MIA implants deployed using the MIA, Minimally Invasive Annuloplasty Device from an open surgical approach
MIA, Minimally Invasive Annuloplasty Device - PercutaneousDevice
Eligible patients will receive implantation of MIA implants deployed using the MIA, Minimally Invasive Annuloplasty Device from a percutaneous approach
Primary outcomes
What the sponsor says the trial is designed to measure.
- Major Adverse EventsTime frame: 30 days
- Reduction in tricuspid regurgitation at 30 daysTime frame: 30 days
Locations
6 sites in 5 countries. Site status is shown where the registry gives one.
Aarhus University Hospital
Aarhus, Denmark · Not yet recruiting
Semmelweis University, Heart and Vascular Center
Budapest, Hungary · Not yet recruiting
Centre of Cardiology, Pauls Stradins Clinical University Hospital
Riga, Latvia · Recruiting
3 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.